Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Graham Webb Back To Basics Ad Campaign Touts “Redefined” Brand

This article was originally published in The Rose Sheet

Executive Summary

Graham Webb will promote the restage of salon-distributed Back To Basics hair care with an aggressive print ad campaign expected to reach 275 mil. people, according to the division of Procter & Gamble's Wella subsidiary

You may also be interested in...



Cosmetics Industry Awaits FDA’s Allergen List While Working To Inform GMP Rulemaking

The Independent Beauty Association does not yet have insight into what ingredients will be listed in the US FDA’s proposed rulemaking for cosmetic allergen labeling – due by 29 June – but is optimistic the agency will consult industry when it comes to setting the compliance timeline. Meanwhile, industry stakeholders are pushing for international harmonization in the agency’s cosmetic GMPs rulemaking.

AI Advancing Quickly, But Same FTC, IP Rules Apply – Attorney

Artificial intelligence opportunities are on the rise for marketers, including in the beauty and personal-care sectors. Reed Smith partner Stacy Marcus offers advice on staying compliant with US consumer protection and copyright laws in this rapidly changing world.

Celebrity Beauty Revenues Soar 58% In 2023, With Rihanna Reigning Again

Fenty Beauty by Rihanna was again the leading celebrity beauty brand in 2023, generating sales of $602.4m globally, followed by the hair-care line of Priyanka Chopra Jonas and cosmetics by Kylie Jenner.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013997

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel